CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03717883
NCT03717883N/ACompleted
CompareCT.gov

Endogenous Molecule Profiling in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

University of North Carolina, Chapel Hill·observational·Posted Oct 24, 2018·Updated Mar 25, 2020

In Brief

An observational study for ADPKD and 2 related conditions. Completed, enrolled 24 participants across 1 site.

Detailed Summary

This is a single center, comparative cohort study to investigate alterations in hepatic transporter function in subjects with autosomal dominant polycystic kidney disease (ADPKD) compared to healthy subjects and subjects with non-ADPKD renal disease. Eligible subjects will be 18-65 years of age and of any race/ethnicity and gender.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsADPKD, Autosomal Dominant Polycystic Kidney Disease, Renal Disease
CountriesUnited States
CollaboratorsNational Institute of General Medical Sciences (NIGMS)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 24, 2018
Enrollment StartSep 17, 2018
Primary CompletionJan 29, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.7 years ago